Page 259 - Read Online

increased oxidative stress. J Affect Disord 2013;150:1238‑41. with memantine, an uncompetitive antagonist of NMDA‑glutamate
40. Magalhaes PV, Jansen K, Pinheiro RT, Colpo GD, da Motta LL, receptor, in Alzheimer’s disease and vascular dementia. Rev Neurol
Klamt F, da Silva RA, Kapczinski F. Peripheral oxidative damage in 2006;42:607‑16.
early‑stage mood disorders: a nested population‑based case‑control 45. Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R,
study. Int J Neuropsychopharmacol 2012;15:1043‑50. Sonobe Y, Mizuno T, Suzumura A. Tumor necrosis factor‑alpha
41. Wiener C, Rassier GT, Kaster MP, Jansen K, Pinheiro RT, Klamt F, induces neurotoxicity via glutamate release from hemichannels
Magalhaes PV, Kapczinski F, Ghisleni G, da Silva RA. Gender‑based of activated microglia in an autocrine manner. J Biol Chem
differences in oxidative stress parameters do not underlie the 2006;281:21362‑8.
differences in mood disorders susceptibility between sexes. Eur 46. Gray JD, McEwen BS. Lithium’s role in neural plasticity and
Psychiatry 2014;29:58‑63. its implications for mood disorders. Acta Psychiatr Scand
42. Ongur D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM, 2013;128:347‑61.
Renshaw PF. Abnormal glutamatergic neurotransmission and 47. Serra G, Koukopoulos A, De Chiara L, Koukopoulos AE, Tondo L,
neuronal‑glial interactions in acute mania. Biol Psychiatry Girardi P, Baldessarini RJ, Serra G. Three‑year, naturalistic,
2008;64:718‑26. mirror‑image assessment of adding memantine to the treatment of 30
43. Atmaca M, Yildirim H. Altered neurochemical ingredient of treatment‑resistant patients with bipolar disorder. J Clin Psychiatry
hippocampus in patients with bipolar depression. Depress Res Treat 2015;76:e91‑7.
2012;2012:485249. 48. La Spada AR. Memantine strikes the perfect balance. Nat Med
44. Tanovic A, Alfaro V. Glutamate‑related excitotoxicity neuroprotection 2009;15:1355‑6.

Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015 251